NDC 39892-0830-01 - MediChoice Triple Antibiotic
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 39892-0830
- Requested NDC
- 39892-0830-01
- Package NDCs from labels
- 39892-0830-1, 39892-0830-01
- Manufacturer
- O&M HALYARD, INC. | Owens & Minor, Inc
- Effective date
- 2025-10-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MediChoice Triple Antibiotic - O&M HALYARD, INC. | Owens & Minor, Inc | O&M HALYARD, INC. | Owens & Minor, Inc | 2025-10-09 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 39892-0830-1 | MediChoice Triple Antibiotic | 144 in 1 CARTON | OINTMENT | 144 | 6 | |
| 39892-0830-1 | MediChoice Triple Antibiotic | 0.9 g in 1 PACKET | OINTMENT | 0.9 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 39892-0830 | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 5 | Current NDC, Legacy NDC, 2 package rows | 20231210_8369f399-6f64-4441-be72-1f16c7306c0a.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| BACITRACIN | ACTIVE INGREDIENT | 58H6RWO52I | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 | |
| NEOMYCIN SULFATE | ACTIVE INGREDIENT | 057Y626693 | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 | |
| POLYMYXIN B SULFATE | ACTIVE INGREDIENT | 19371312D4 | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 | |
| BACITRACIN | ACTIVE MOIETY | 58H6RWO52I | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 | |
| NEOMYCIN | ACTIVE MOIETY | I16QD7X297 | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 | |
| POLYMYXIN B | ACTIVE MOIETY | J2VZ07J96K | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 | |
| PETROLATUM | INACTIVE INGREDIENT | 4T6H12BN9U | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Proficient Rx LP | 105095e3-843e-4153-adc9-266dd14929a2 | 2024-01-01 | Warnings | 4T6H12BN9U |
| Bacitracin | BACITRACIN | Proficient Rx LP | e1166948-5d80-44c2-a20d-78be631647d9 | 2024-01-01 | Warnings | M004 58H6RWO52I |
| TRIPLE ANTIBIOTIC | BACITRACIN ZINC NEOMYCIN SULFATE POLYMYXIN B SULFATE | Proficient Rx LP | 949c5b44-ee52-4913-8872-39181d319998 | 2024-01-01 | Warnings | M004 204602 057Y626693 19371312D4 |
| CeraVe Developed with Dermatologists Healing | PETROLATUM | L'Oreal USA Products Inc. | 1b3ad3e8-cbac-4a92-84e2-4f3ab4512d95 | 2023-12-31 | Warnings | 4T6H12BN9U |
| CeraVe Developed with Dermatologists Baby Healing | PETROLATUM | L'Oreal USA Products Inc. | fe665bbc-1172-4f59-acc6-8d5c179693b6 | 2023-12-31 | Warnings | 4T6H12BN9U |
| MAXITROL | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | Sandoz Inc | 5776c435-ac60-49b6-8db1-23a3012b9155 | 2023-12-29 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Triple Antibiotic Plus | POLYMYXIN B SULFATE, BACITRACIN ZINC, NEOMYCIN SULFATE, PRAMOXINE HCL | Cosette Pharmaceuticals, Inc. | 69d911c2-cb89-2241-35f8-c83acfe18249 | 2023-12-21 | Warnings | M004 19371312D4 |
| Bacitracin | BACITRACIN | Cosette Pharmaceuticals, Inc. | 630e0841-baf2-e9fa-b309-ad1a5f95da3b | 2023-12-20 | Warnings | M004 58H6RWO52I |
| Triple Antibiotic | POLYMYXIN B SULFATE, BACITRACIN ZINC AND NEOMYCIN SULFATE | Cosette Pharmaceuticals, Inc. | 39893365-c94f-bc83-67f6-0005d5f2aa24 | 2023-12-20 | Warnings | M004 204602 057Y626693 19371312D4 |
| Family Wellness HEMORRHOID | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | FAMILY DOLLAR (Family Wellness) | 16ceb129-5c0a-428a-a867-cfbbb08bb62a | 2023-12-11 | Warnings | 4T6H12BN9U |
| Altalube | MINERAL OIL AND PETROLATUM | Altaire Pharmaceuticals Inc. | eb65004c-c3a7-4079-bd75-f2857d30c68a | 2023-12-09 | Warnings | 4T6H12BN9U |
| Mayinglong Hemorrhoidal | PETROLATUM, ZINC OXIDE | Mayinglong Pharmaceutical Group Co., Ltd. | b14192ea-1bf7-da6a-e053-2a95a90a5b5e | 2023-12-08 | Warnings | 4T6H12BN9U |
| Hemorrhoidal Pain Relief | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | WALGREENS | 03bc5c1a-d493-5082-e063-6394a90ae87b | 2023-12-05 | Warnings | 4T6H12BN9U |
| Welmedix HomeCare PRO Fragile Skin Protectant | PETROLATUM | Welmedix LLC | 6e8d7151-c7fc-4b8f-9343-4a9f0f4e37cf | 2023-12-05 | Warnings | 4T6H12BN9U |
| Welmedix HomeCare PRO Extra Strength Rapid Rash Relief | PETROLATUM, ZINC OXIDE | Welmedix LLC | 551e6cce-7adc-4e98-baff-2703b83d7526 | 2023-12-05 | Warnings | 4T6H12BN9U |
| Hemorrhoidal Pain Relief Cream | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | WALGREENS | 03bbe146-f185-bcfa-e063-6394a90a85bf | 2023-12-04 | Warnings | 4T6H12BN9U |
| Triple Antibiotic | POLYMYXIN B SULFATE, BACITRACIN ZINC AND NEOMYCIN SULFATE | Proficient Rx LP | 524d65e7-9dc6-47b0-a924-46a765fa1869 | 2023-12-01 | Warnings | M004 204602 057Y626693 19371312D4 |
| Viabecline | TETRACYCLINE HYDROCHLORIDE | Accuria, LLC | 9fd7041a-6c23-4332-90fe-759bb4aea2ae | 2023-12-01 | Warnings | M004 |
| Petrolatum Jelly | PETROLATUM | NEW PRIDE CORP | f6634410-fa1f-7987-e053-2995a90abb06 | 2023-12-01 | Warnings | 4T6H12BN9U |
| Bacitracin | BACITRACIN | Proficient Rx LP | 65f8fd49-1882-4eac-9c0e-d63968da33d4 | 2023-12-01 | Warnings | M004 58H6RWO52I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.